Form 4: BioMarin Director Exercises Stock Options and Disposes of Shares
SEC Form 4 Filing
Director Richard A. Meier exercised stock options and disposed of shares of BioMarin Pharmaceutical Inc. on June 3, 2024.
Summary
- On June 3, 2024, Richard A. Meier, a director of BioMarin Pharmaceutical Inc., exercised stock options to acquire 6,600 shares of common stock at a price of $63.10 per share.
- Following the exercise of these options, Meier disposed of 5,451 shares to cover taxes at $76.41.
- After these transactions, Meier directly owns 120,776 shares of BioMarin common stock.
- Meier also holds options to purchase 0 shares of common stock after the transactions from this specific stock option grant.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating neutral sentiment as it simply reports transactions.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 09/04/2014 | Original date of stock option grant |
| 06/03/2024 | Date of transaction: exercising stock options and disposing of shares |
| 06/03/2024 | Stock options exercisable date |
| 06/03/2024 | Stock options expiration date |
| 06/04/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.